Pruritus relief is the greatest treatment priority for those with moderate to severe AD, despite variations in priorities across patient subgroups.

Topical therapies may offer more favorable tolerability profiles than ablative treatments for immunocompetent adults with external anogenital warts.

Delgocitinib cream has a significant dose-response relationship for achieving 75% improvement in EASI among patients with AD at 8 weeks.

Though laboratory abnormalities are common with ritlecitinib therapy for alopecia areata, the majority are mild and not clinically significant.

Nearly 40,000 bottles of widely sold eye drops are being pulled from shelves because the maker cannot guarantee the product is sterile.

More than 3600 bottles of Thyroid Tablets, USP 30 mg were recalled nationwide after lab tests showed the pills may be too strong.

Socrodeucitinib significantly reduced PASI scores at 12 weeks of treatment among adults with moderate to severe plaque psoriasis.

A skin biopsy is a common medical procedure in which a small sample of skin is removed for examination; aftercare can help ...